In a preclinical evaluation using a bleomycin-induced pulmonary fibrosis mouse model, attenuating effects against pulmonary fibrosis were observed using neutralizing antibodies, peptides, and gene silencing strategies targeting the PTHrP<sub>1-34</sub>/parathyroid hormone 1 receptor axis. Here, PTHLH is linked to pulmonary fibrosis.